Chronic allograft nephropathy: Causes of death and mortality risk factors - A review of the last decade in Spain

被引:3
作者
Alonso, A [1 ]
Oliver, J [1 ]
机构
[1] Hosp Juan Canalejo, Serv Nefrol, La Coruna, Spain
关键词
D O I
10.1016/j.transproceed.2004.03.038
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Improved immunosuppressive regimens and management strategies in renal transplantation (RT) have increased patient and graft survival during the last years. The aim of our study was to analyze the causes, risk factors, and evolution of mortality after renal transplantation. Methods. We studied 3365 renal transplant recipients in adults (>18 years) who survived at least 1 year after transplantation in Spain during 1990, 1994, and 1998. The mortality rates and risk factors were analyzed employing single and multivariate Cox regression. Results. The follow-up was shortest (maximum 2.5 years) for recipients transplanted in 1998. When we consider an identical follow-up period (2.5 years) for all patients, we did not observe a statistical difference in patient survival and causes of death in the three analyzed periods. Mortality was higher for men and for patients over 60 years. Cardiovascular diseases (CVD) and neoplasia were the most frequent causes of death. Graft dysfunction, as determined by creatinine level or proteinuria range in the first months, were significant factors associated with a higher risk for cardiovascular and infectious deaths. Conclusions. During the last decade in Spain, patient survival after RT (2.5 years follow-up) has remained stable. Recipient age (>60 years), male gender, and graft dysfunction in the first year were associated with a higher risk of death especially due to CVD.
引用
收藏
页码:765 / 767
页数:3
相关论文
共 12 条
[1]  
Amenábar JJ, 1999, NEFROLOGIA, V19, P203
[2]   Patient survival after renal transplantation III: The effects of statins [J].
Cosio, FG ;
Pesavento, TE ;
Pelletier, RP ;
Henry, M ;
Ferguson, RM ;
Kim, S ;
Lemeshow, S .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 40 (03) :638-643
[3]   Patient survival after renal transplantation: II. The impact of smoking [J].
Cosio, FG ;
Falkenhain, ME ;
Pesavento, TE ;
Yim, S ;
Alamir, A ;
Henry, ML ;
Ferguson, RM .
CLINICAL TRANSPLANTATION, 1999, 13 (04) :336-341
[4]  
GJERTSON DW, 1998, CLIN TRANSPL, V399
[5]   Improved graft survival after renal transplantation in the United States, 1988 to 1996. [J].
Hariharan, S ;
Johnson, CP ;
Bresnahan, BA ;
Taranto, SE ;
McIntosh, MJ ;
Stablein, D .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (09) :605-612
[6]   Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation [J].
Meier-Kriesche, HU ;
Baliga, R ;
Kaplan, B .
TRANSPLANTATION, 2003, 75 (08) :1291-1295
[7]   The impact of body mass index on renal transplant outcomes: A significant independent risk factor for graft failure and patient death [J].
Meier-Kriesche, HU ;
Arndorfer, JA ;
Kaplan, B .
TRANSPLANTATION, 2002, 73 (01) :70-74
[8]  
Meier-Kriesche HU, 2001, J AM SOC NEPHROL, V12, P1293, DOI 10.1681/ASN.V1261293
[9]   Proteinuria after renal transplantation affects not only graft survival but also patient survival [J].
Roodnat, JL ;
Mulder, PGH ;
Rischen-Vos, J ;
van Riemsdijk, IC ;
van Gelder, T ;
Zietse, R ;
Ijzermans, JNM ;
Weimar, W .
TRANSPLANTATION, 2001, 72 (03) :438-444
[10]  
Schaubel DE, 2002, CAN MED ASSOC J, V167, P137